Serum Neuropeptide Y: A Potential Prognostic Marker of Intracerebral Hemorrhage

Table 1

Baseline characteristics of ICH patients according to different prognosis at 3 months.

Characteristics	3-month prognosis		values
	Good ()	Poor ()
Demographics or anthropometrics
Age (years)			0.566
Gender, male/female	89/51	138/86	0.707
Body mass index (kg/m^2)			0.581
Medical history
Hypertension	81	135	0.649
Diabetes mellitus	30	52	0.692
Hyperlipidemia	76	118	0.765
Coronary artery disease	22	41	0.525
Clinical severity
NIHSS scores (points)			0.036
Hematoma volume (ml)			0.039
Laboratory data
Total cholesterol (mmol/l)			0.425
Triglycerides (mmol/l)			1.000
LDL cholesterol (mmol/l)			0.087
HDL cholesterol (mmol/l)			1.000
Blood glucose (mmol/l)			0.237
Neuropeptide Y (ng/ml)			<0.001

NIHSS: National Institutes of Health Stroke Scale; LDL: low-density lipoprotein; HDL: high-density lipoprotein.